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Abstract
Epidemiologic evidence shows that the risk of ovarian
cancer is decreased following childbirth. We examined the
time points when the decreased risk of postpartum
maternal ovarian cancer reaches the lowest point and
whether the protective effect diminishes over time. A
case-control study nested within the Swedish Fertility
Register included 10,086 cases of epithelial ovarian cancer
recorded in the Swedish Cancer Register from 1961 to
2001. From the Fertility Register, 49,249 eligible subjects
matched to the cases by age were selected as controls. The
analysis contrasted risk between adjacent parities through
logistic regression models that included indicator varia-
bles representing each year of age, age at delivery, and
time since delivery. Compared with nulliparous women,
uniparous women had a transient decrease in maternal
ovarian cancer risk at 2 years after delivery (spline-derived
odds ratio, 0.71; 95% confidence interval, 0.53-0.95, for
those delivered at age 25 years) and maintained a lower
risk for 4 years postpartum. Similar transient decreases
were observed in biparous women compared with uni-
parous women and in women with three parities com-
pared with biparous women. The protective effect of
childbearing seemed to diminish with time. The transient
decrease in postpartum ovarian cancer risk may define
the latent period required for pregnancy hormones in
clearing out ovarian cells that have undergone early
stages of malignant transformation. The period before
the risk increases again could indicate the period required
for ovarian cancer induction. (Cancer Epidemiol Bio-
markers Prev 2006;15(12):2508–13)
Introduction
Increasing parity has consistently been shown to reduce risk of
ovarian cancer (1-8). There is also epidemiologic evidence that
the risk of ovarian cancer is lower in women who have an
older age at first birth (8-10). With conflicting results, several
investigators have examined the association between time
since last birth and the risk of ovarian cancer (8, 9, 11). Two
studies (8, 9) found evidence of a significantly increased risk of
ovarian cancer along with longer time since last birth, whereas
others have failed to detect such a temporal trend (11).
Whiteman et al. (9) reported a lower risk of ovarian cancer in
the category of <10 years since last birth. However, due to
sample size limitations and linear extrapolation from models
using continuous (1) or wide intervals for time-related
variables (8-11) in previous studies, it remains unclear whether
there are specific time points following birth when the risk of
ovarian cancer is at the lowest.
A recent hypothesis suggests that a pregnancy clears from
the ovaries cells that have already undergone malignant
transformation (1). The likelihood that such transformed cells
exist should increase with age, as does the incidence of clinical
disease. The effect associated with pregnancy clearance may be
mediated by placental or ovarian hormones associated with
childbirth (3). The mechanism of clearance would accommo-
date the observation that a pregnancy at older age seems to
provide a greater reduction in risk than a pregnancy at
younger age. Elimination of the initiated cells itself should
have an effect that diminishes with increased time since a
delivery. To examine this hypothesis in more details, we
applied a single-year categorical modeling approach (12) in a
nested case-control study based on information from Swedish
nationwide population registers.
Materials and Methods
Members of the study cohort were identified in the nationwide
Swedish Fertility Register, which includes all female resident
citizens of Sweden born from 1925 and thereafter. The
database contains fertility information on number (including
nulliparity), gender, and dates of live births, if any, for >3.4
million women. Information on dates of birth for biological
and adopted children born between 1943 and 1960 was
collected retrospectively at the 1960 Census. From 1961, only
biological children were included, with all new births added
annually from vital statistics records. The quality of informa-
tion on reproductive history (i.e., number and dates of births)
is generally high, with the exception of the oldest cohorts
(mainly women born on 1925-1929) for whom individual
fertility levels may be both underestimated and overestimated.
Use of the unique national registration number assigned to all
individuals at birth or time of first residency permits record
linkage and retrieval of information from other population-
based registers (13). Vital statistics for women in the Fertility
Register is updated annually based on information obtained
from the National Population Register.
Since 1958, the Swedish National Cancer Register receives
reports about all newly diagnosed malignant tumors from
both the physician who made the diagnosis and the
pathologist/cytologist who confirmed the diagnosis (14).
Each histopathologically confirmed cancer case is assigned
a pathologic code. The Cancer Register also contains
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information about residence at the time of diagnosis as well
as the hospital and pathology department where the
diagnosis was made. The completeness of cancer registration
is considered to be close to 100% (14).
Thus, members of the study cohort were all women who
were born on and after 1925 and listed in the Fertility Register.
We adopted a nested case-control sampling design to allow
more efficient analyses. Case subjects were cohort members
diagnosed from 1961 to 2001 with incident invasive epithelial
ovarian cancer (ICD-7: 175.0 with a pathology code of 096 for
adenocarcinoma, 196 for undifferentiated carcinoma, or 146 for
squamous cell cancer; ref. 1), as ascertained from the records of
the Swedish National Cancer Register. For each woman with
ovarian cancer, five comparison control subjects were ran-
domly selected from cohort members listed in the Fertility
Register. These women were individually matched by birth
year with the index case, were residents of Sweden at the time
when the case was diagnosed, were alive at least to the date of
the diagnosis for the index case, and had not been previously
diagnosed with ovarian cancer. For both cases and controls,
only live births before the index case’s date of diagnosis were
included in the analyses.
Statistical Analysis. To detect whether the relative rate of
ovarian cancer varies over time after a delivery and whether
there is a nadir in ovarian cancer risk after giving birth, our
analyses focused on the exposure contrast between adjacent
parities, assuming that, without childbirth and with compa-
rable other risk factors, uniparous women would have the
same age-specific rates of ovarian cancer as nulliparous
women (15). Similarly, biparous women, given the same age
at first birth but without the second birth, would have had
the same age-specific rates as uniparous women, and so on.
Odds ratio (OR) was used as an estimate of relative risk in
our study. To obtain OR estimates associated with single-year
time variables, we further refined the logistic regression
model with categorical predictor variables as suggested by
Heuch et al. (16). We generated indicator variables for each
individual year of subject’s age (attained age, i.e., case
subject’s age at diagnosis or control subject’s age at
identification), age at each delivery, and time since last
delivery (12). Age was a matching variable and was adjusted
for in the analyses using single-year indicator variable
representation. For time since delivery, the first category
(<1 year since delivery) served as the reference category. For
age at first, second, and third delivery, the category with the
largest number of subjects was chosen as the reference
category for stability of effect estimate. Conceptually, our
model can be partitioned into two parts: the first is a model
with age (baseline effect) using the data of women with one
less parity (e.g., nulliparous); the second is a model with age
and age at delivery for women with one additional parity
(e.g., uniparous). Assuming that, without childbirth, unipar-
ous women would have the same baseline age effect as
nulliparous women, relative risk comparing uniparous with
nulliparous women could be estimated by subtracting the
first from the second model. The residual effect of age (after
removing the baseline effect of age) for uniparous women
could then be further decomposed into age at delivery and
year since delivery (12). For the purpose of graphic
presentation, we first fit a six-degree polynomial function to
the categorical-specific relative risk point estimates to identify
inflexion points in trend over years since delivery (17). We
then fit a power (quadratic or cubic) spline model to the
original data using as knots the corresponding inflexion
points identified from the fitted polynomial functions (18).
Usually, a quadratic spline is flexible enough for modeling a
nonlinear trend for epidemiologic purposes (18), whereas a
cubic model will be used if likelihood ratio test shows that
the cubic spline model is significantly better than the
quadratic spline model. The graph presents the relative risk
since last delivery for women who gave last birth at a
particular year compared with women with one less parity, at
the same age.
Results
This nested case-control study included subjects who were 13
years or older and consisted of a total of 10,086 epithelial
ovarian cancer patients that had matching information in the
Fertility Register and 49,249 control subjects.
The first analysis focused on the comparison between
uniparous and nulliparous women; 2,534 cases and 10,675
controls were nulliparous, whereas 2,103 cases and 8,796
controls were uniparous. Table 1 shows the distribution of
these subjects according to age at diagnosis and age at
delivery. Most cases were in the age range 40 to 59 years
(55% for nulliparous and 59% for uniparous). Table 2 shows
relative risk estimates and 95% confidence intervals (95% CI)
associated with each year of age at delivery and each
postpartum year since delivery, adjusting for attained age,
from the categorical model using single-year indicator variable
representation for all three variables. Compared with <1 year
since delivery, relative risk estimates were the lowest around 2
years after delivery, and were generally increased from 5 years
postpartum and onward (Table 2). However, none of these
estimates were significantly different from unity.
Figure 1 displays relative risk estimates associated with each
postpartum year since delivery comparing uniparous women
Table 1. Distribution of nulliparous and uniparous epithelial ovarian cancer cases and controls by age at delivery and age
at diagnosis
Age at diagnosis (y) Group Nulliparous Uniparous, age at delivery (y)
15-19 20-24 25-29 30-34 35-39 40-48
13-19 Cases 49 2 0 0 0 0 0
Controls 244 6 0 0 0 0 0
20-29 Cases 233 19 38 30 0 0 0
Controls 1,000 72 216 137 0 0 0
30-39 Cases 343 34 96 72 39 6 0
Controls 1,283 97 276 350 205 40 0
40-49 Cases 653 75 193 156 86 43 7
Controls 2,680 221 738 642 379 192 40
50-59 Cases 737 81 205 207 124 54 9
Controls 3,148 295 905 891 516 222 64
60-69 Cases 424 47 144 113 79 30 6
Controls 1,912 184 564 548 364 159 36
70-76 Cases 95 9 33 32 15 15 4
Controls 408 42 134 140 89 24 8
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who had an age at first delivery of 25, 30, or 35 years with
nulliparous women. The solid lines were cubic spline-
smoothed lines (compared with quadratic spline model,
likelihood ratio test: m2 = 12.62 with 1 degrees of freedom,
P = 0.0004) to summarize general trends of postpartum risk of
ovarian cancer. The spline model fit closely to the model using
single-year indicator variables (likelihood ratio test: m2 = 50.43
with 53 degrees of freedom, P = 0.57). The spline model had
a significantly better fit comparing with the model using year
since delivery as a continuous variable (likelihood ratio test:
m2 = 10.22 with 4 degrees of freedom, P = 0.04), indicating
departure from linearity. Relative risks of developing ovarian
cancer for uniparous women who gave birth at an older age
were generally lower than those who gave birth at younger
ages (Table 2). Interaction between age at delivery (as a
continuous variable) and the terms for year since delivery in
cubic spline regression was not statistically significant
(P = 0.52). Figure 1 shows that the relative risk of developing
ovarian cancer for uniparous women was the lowest around 2
years after delivery: spline model–derived OR (95% CI) was
0.71 (0.53-0.95) for those with an age of 25 years at delivery,
0.62 (0.45-0.85) for age 30 years at delivery, and 0.63 (0.43-0.93)
for age 35 years at delivery. Uniparous women who gave birth
at 30 or 35 years of age had a relative risk of ovarian cancer that
was always lower than nulliparous women. For those who
gave birth at 25 years of age, the OR was >1.0 during the 13 to
28 years postpartum (spline model-derived OR, 1.01; 95% CI,
0.47-2.16, for 13 years postpartum; Fig. 1).
We next compared biparous (3,373 cases and 16,880
controls) with uniparous women (2,103 cases and 8,796
controls) to estimate relative risk associated with each year
since the second delivery. Age at second delivery was not
associated with ovarian cancer risk among biparous women
after adjusting for age, age at first delivery, and year since the
second delivery. Figure 2 displays graphically the findings on
time since the last delivery from quadratic spline regression.
Biparous women had a transient decrease in risk with a nadir
at 3 years after the second delivery: spline model-derived OR
(95% CI) was 0.58 (0.45-0.74) for those with an age of 25 years
at the second delivery, 0.60 (0.48-0.76) for age 30 years at
delivery, and 0.65 (0.49-0.86) for age 35 years at delivery, and
the risk gradually increased after that.
Finally, we compared women with three parities (1,455
cases and 8,658 controls) with biparous women (3,373 cases
and 16,880 controls) to estimate relative risk associated with
each year since the third delivery. Age at the third delivery
was not associated with ovarian cancer risk among women
with three parities after adjusting for age, age at the first and
the second delivery, and year since the third delivery. Relative
risk estimates associated with time since delivery from the
spline model indicated that, compared with <1 year since
delivery, statistically significant transient decrease in risk at 3
years after the third delivery was observed for women with
age 30 years at the third delivery (OR, 0.58; 95% CI, 0.41-0.83),
whereas a borderline statistically significant transient decrease
in risk at 3 years after the third delivery was observed for those
with ages 25 years (OR, 0.66; 95% CI, 0.44-1.00) and 35 years
(OR, 0.74; 95% CI, 0.51-1.06) at the third delivery. The relative
risk then gradually increased toward unity until 13 years after
giving the third birth (Fig. 3).
Discussion
Our results indicate that there is a time window of 2 to 3 years
after giving birth when maternal ovarian cancer risk reaches its
lowest. Models using continuous variable representations,
which assume linearity of effect for time since delivery, are
likely to miss this nadir in risk. The results of lower risk within
10 years since last birth are compatible with that observed by
Titus-Ernstoff et al. (8) and Whiteman et al. (9). Biparous
women and women with three parities in turn had a similarly
lower risk of ovarian cancer than that in women with one less
parity. Pike et al.’s study (10) has also shown that the
additional births further reduce the risk of ovarian cancer.
This study is among the largest epidemiologic analyses of
ovarian cancer. Selection and information biases are mini-
mized since the case-control sampling was nested within a
well-defined cohort and the exposure information was
recorded independent of outcome. The Fertility Register
contains no information on stillbirths, and recorded parity
status is based on number of live births. However, stillbirths
Table 2. ORs and 95% CIs of developing epithelial ovarian
cancer in uniparous women, based on single-year categor-
ical model with separate terms for age at first delivery and
time since delivery
Variables Cases (n) Controls (n) OR (95% CI)
Parity
Nulliparous 2,534 10,675 1.00 (Reference)
Uniparous 2,103 8,796 0.82* (0.45-1.51)
Age at delivery (y)
15 0 14 0.00 (0.00-1)
16 19 58 1.36 (0.78-2.39)
17 41 160 1.07 (0.72-1.59)
18 80 282 1.17 (0.86-1.60)
19 127 403 1.35 (1.03-1.78)
20 115 529 0.92 (0.70-1.21)
21 167 526 1.33 (1.03-1.72)
22 124 582 0.89 (0.68-1.16)
23 154 579 1.11 (0.86-1.43)
24 149 617 1.00 (Reference)
25 134 583 0.94 (0.73-1.22)
26 140 584 0.99 (0.77-1.29)
27 135 571 0.97 (0.75-1.26)
28 113 510 0.91 (0.69-1.19)
29 88 460 0.79 (0.59-1.05)
30 83 413 0.82 (0.61-1.10)
31 84 324 1.06 (0.78-1.44)
32 63 302 0.86 (0.62-1.19)
33 55 263 0.86 (0.61-1.21)
34 58 251 0.94 (0.67-1.33)
35 43 215 0.83 (0.57-1.22)
36 37 139 1.12 (0.74-1.69)
37 28 130 0.92 (0.59-1.45)
38 21 82 1.09 (0.65-1.84)
39 19 71 1.15 (0.67-1.98)
40 12 53 0.98 (0.51-1.89)
Years since delivery
<1 14 74 1.00 (Reference)
1 30 165 0.92 (0.46-1.85)
2 22 149 0.75 (0.36-1.56)
3 24 118 0.99 (0.48-2.05)
4 23 115 0.99 (0.48-2.06)
5 23 97 1.12 (0.54-2.34)
6 27 100 1.36 (0.66-2.78)
7 24 98 1.21 (0.58-2.52)
8 24 129 0.92 (0.44-1.89)
9 32 119 1.38 (0.68-2.77)
10 24 107 1.13 (0.54-2.34)
11 28 140 1.00 (0.49-2.03)
12 33 132 1.24 (0.62-2.49)
13 37 150 1.26 (0.63-2.50)
14 50 141 1.83 (0.94-3.56)
15 35 141 1.27 (0.64-2.54)
16 48 180 1.37 (0.71-2.67)
17 56 211 1.38 (0.72-2.65)
18 51 204 1.31 (0.67-2.52)
19 55 201 1.42 (0.73-2.73)
20 56 234 1.25 (0.65-2.41)
NOTE: For brevity, results were not shown for age at delivery from 41 to 48 years
and for year since delivery from 21 to 58 years.
*Estimated effect of uniparity with age at delivery and year since delivery at the
reference level (i.e., age at delivery of 24 years and time since delivery <1 year)
relative to nulliparity, adjusting for age in single-year-indicator representation.
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represented only a small proportion of all births in Sweden
with a decrease from 1.67% in 1955 to 0.39% in 1985 (19).
Potential residual bias from excluding stillbirths and misclas-
sification of parity from adopted children for a small number
of subjects in the oldest birth cohorts are likely to be negligible
and nondifferential.
We could not examine and control for confounding by age at
menarche, age at menopause, oral-contraceptive use, and
anthropometric factors. A study on mathematical models of
ovarian cancer incidence showed that age at menarche and age
at menopause were related to cumulative risk of ovarian
cancer (20), whereas other studies observed that the associa-
tion between risk of ovarian cancer and age at menarche or age
at menopause was almost null (8, 10, 21). The magnitude of
collective confounding by anthropometric factors is likely to be
small (22-25). Inability to control for oral contraceptive use is a
major limitation in our analysis, as oral contraceptive use has
been found in most studies to be inversely associated with
ovarian cancer risk and such use also leads to delayed
childbirth. However, our results were essentially unaltered
when the analyses were restricted to the oldest birth cohort
(1925-1935) in which the likelihood of exposure to oral
contraceptives or fertility drugs was considered to be small
(data not shown). Confounding by age, parity, and age at first
delivery is potentially more substantial and was accounted for
in the analyses.
Due to sample size limitation, most previous studies on the
time-varying effects of childbirth on maternal ovarian cancer
risk fit models using continuous forms or broad intervals for
age, age at delivery, and year since last delivery (8-11, 20, 21).
Consequently, effect estimates for extreme categories were
derived from linearly extrapolated values in such models and
yearly variations in postpartum risk could not be adequately
examined. Thus far, no study has investigated change in
ovarian cancer risk associated with time since last delivery
while taking into account the effect of age and age at delivery.
In the statistical model using categorical variables as
suggested by Heuch et al. (16), relative risk associated with
different time periods since childbirth could be estimated
while taking age and age at delivery into consideration. The
validity of that model depends on the tenability of at least two
assumptions: (a) the effects of age are the same between
women of different parities (e.g., uniparous versus nullipa-
rous; biparous versus uniparous) and (b) the effect of age at
delivery was homogeneous over age (not modified by age;
ref. 26). The two assumptions were, however, judged to
impose no restriction on the interpretation of the effect of time
since delivery (27). As originally proposed in the model of
Figure 1. OR estimates associated with each year
since delivery for uniparous women with age at
delivery of 25 years ( w ), 30 years (4), or 35 years
(j) compared with nulliparous women. Solid lines,
fitted results from power spline logistic regression.
The power spline logistic regression core model is
b0 + bp (parity) + ba (age) + baafd (age at first
delivery) + b1m1 + b2m
2
1 + b3m
3
1 + b4m
2
2 + b5m
2
3,
where age and age at first delivery are one-year
categorical time variables. m1 is the continuous
variable of years since first delivery. m2 = m1  3
if m1 > 3, otherwise m2 = 0. m3 = m1  38 if
m1 > 38, otherwise m3 = 0. b1 = 0.0706,
b2 = 0.0204, b3 = 0.000032, b4 = 0.0231, b5 =
0.0021.
Figure 2. OR estimates associated with each year
since second delivery for biparous women with age
at second delivery of 25 years ( w ), 30 years (4), or
35 years (j) compared with uniparous women.
Solid lines, fitted results from quadratic spline
logistic regression. The quadratic spline logistic
regression core model is b0 + bp (parity) + ba (age)
+ baafd (age at first delivery) + baasd (age at second
delivery) + b1m1 + b2m
2
1 + b3m2
2 + b4m3
2, where age,
age at first delivery, and age at second delivery are
one-year categorical time variables. m1 is the
continuous variable of years since second delivery.
m2 = m1  4 if m1 > 4, otherwise m2 = 0.
m3 = m1  25 if m1 > 25, otherwise m3 = 0. b1 =
0.1520, b2 = 0.0231, b3 = 0.0237, b4 = 0.0003.
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Heuch et al. (16), categories of age, time since delivery, and age
at delivery were set in broad ranges, necessitating additional
assumption of homogeneity in relative risk estimates within
levels of each variable (26). With the use of single-year
indicator representation for age, age at delivery, and years
since delivery, the refined model in our analysis did not
impose a functional form for the effect of year since delivery
and allowed the estimation of nonlinear effects of time since
delivery. With the large quantity of data, we were able to
estimate relative risk associated with each individual year after
delivery while controlling for current age and age at first birth
also in single-year-indicator representation.
Incessant ovulation (28) and high serum concentration of
gonadotropins (29) have been the two major hypotheses for
explaining the biological mechanism behind the development
of ovarian cancer. Neither hypothesis, however, can fully
explain the protective effect of pregnancy. The incessant
ovulation hypothesis is consistent with the observed protective
effect of interrupted ovulation due to childbearing or oral
contraceptive use, but it cannot explain why oral contraceptive
use for longer periods does not provide further protection
(1, 2). Also, it cannot explain why the protective effect of
interrupted ovulation seems unequal for different parities
(1, 2). The effect of ovulation suppression from a pregnancy
should be equal among women of different ages, but seems to
be stronger in older parous women (1). The hypothesis would
also predict a reduced risk with early age at menopause, which
has not been convincingly shown (2). The gonadotropin
hypothesis fits also with the established effects of parity and
oral contraceptive use and would also accommodate a possible
association with fertility drugs. However, owing to its effects
on gonadotropin concentrations, early menopause should
increase the risk, but no such effect has been documented
(8). It has been suggested that gonadotropins, while involved
in the feedback regulations of ovarian steroid hormones, may
not in themselves be responsible for changes in ovarian cancer
risk (3). Recently, studies that examined the association
between twinning and maternal risk of epithelial ovarian
cancer have yielded findings that are in direct conflict with the
predictions of these two hypotheses. Mothers of dizygotic
twins seem to be exposed to higher levels of follicle-
stimulating hormone and may also double ovulate more
frequently (30). Based on the two main hypotheses, risk of
ovarian cancer in mothers of twins would be predicted to be
elevated not only by excessive hormonal stimulation of
ovarian cells, but also due to lifelong patterns of ovulation
that predispose to malignant change. However, an excess risk
of ovarian cancer in mothers with multiple births has not been
shown (8, 30-32). Thus, although many findings from
epidemiologic studies are consistent with these two principal
hypotheses, alternative hypotheses need to be proposed to
accommodate observations that could not be readily inferred
from them (1, 3). Findings based on the analyses of earlier
experience of the present study cohort have prompted the
formulation of a third hypothesis suggesting that the protec-
tive effect of childbearing can be explained by pregnancy-
induced clearance of malignantly transformed cells from the
ovaries (1). Such a mechanism would dictate that elimination
of the initiated cells itself should have an effect that diminishes
with increased time since a delivery. Study subjects in the
previous analysis (1) had a maximum age at diagnosis of 59
years and thus had a limited power to evaluate whether the
protective effect may diminish with increased time since
pregnancy. In our study, compared with nulliparous women,
uniparous women with older age at delivery had a more
pronounced reduction in risk. The findings on pattern of
relative risk for ages 25 and 35 years at delivery are consistent
with the results in Pike et al.’s study (10). Increasing parity has
consistently been shown to reduce ovarian cancer risk in
epidemiologic studies (1-8), an association that was also
confirmed in the current study (data not shown). More
importantly, we were able to show that the risk of ovarian
cancer is reduced soon after a birth and the protective effect
diminished with time, consistent with the hypothesis of a
pregnancy-induced clearance effect. Rostgaard et al.’s study
(33) using a mathematical model based on the cell clearance
hypothesis also showed that a decreased age-specific invasive
ovarian cancer incidence rate ratios in the first few years after
an pregnancy for women who have been pregnant only once in
younger ages (20 or 25 years) compared with nulligravid
women.
Our observations have given further support to the
pregnancy clearance hypothesis (1). The effect associated with
pregnancy clearance may be mediated by placental or ovarian
hormones associated with childbirth and is supported by
findings in both animal and human studies suggesting that
elevated levels of progesterone increase apoptosis in maca-
que’s ovarian epithelial cells (34, 35) and that the combination
oral contraceptive formulations with high-progestin potency
seem to be associated with a greater reduction in ovarian
cancer risk than those with low progestin potency (36). In
addition, the period of 12 or more years observed in our
analysis before the protective effect of a childbirth diminishes
might provide further etiologic insight into the latent period
Figure 3. OR estimates associated with each year
since third delivery for women who have three
parities with age at third delivery of 25 years ( w ),
30 years (4), or 35 years (j) compared with bipa-
rous women. Solid lines, fitted results from quad-
ratic spline logistic regression. The quadratic spline
logistic regression core model is b0 + bp (parity) +
ba (age) + baafd (age at first delivery) + baasd (age
at second delivery) + baatd (age at third delivery) +
b1m1 + b2m
2
1 + b3m
2
2 + b4m
2
3, where age, age at
first delivery, and age at second delivery are one-
year categorical time variables. m1 is the continuous
variable of years since second delivery. m2 =
m1  3 if m1 > 3, otherwise m2 = 0. m3 = m1 
14 if m1 > 14, otherwise m3 = 0. b1 = 0.3159,
b2 = 0.0628, b3 = 0.0660, b4 = 0.0035.
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for the induction of ovarian cancer. Assuming that pregnancy-
dependent clearance effect clears from the ovaries the trans-
formed cells, leading to the observed transient decrease in risk,
the period that is required for the risk to return to the reference
level can reasonably be considered as the time window
required for a newly transformed cell to become clinically
manifested. If the latency between ovarian cancer initiation
and clinical manifestation can be determined, it may lead to
development of effective strategies for early detection and
intervention of ovarian cancer.
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